EP News Bureau

Sigachi Industries, a leading global manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs),…

The government is considering a separate licensing framework for bulk drugs, active pharmaceutical ingredients (APIs) and key…

Dr. Reddy’s Laboratories announced the launch of Hevaxin, a novel recombinant vaccine for the prevention of Hepatitis E virus…

India’s healthcare and pharmaceutical industries stand at an inflection point. The sector grew at a remarkable 17.5 per cent CAGR…

When the Central Drugs Standard Control Organization (CDSCO) revised Good Manufacturing Practice norms under Schedule M in…

Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue…

Pharmaceutical firms may no longer have to appear in courts in case of "certain minor contraventions" and instead, they can pay a…

What inspired you to write The Dual Mandate in B2B, and how is it different from your earlier book? My inspiration came from a…

The leadership of Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level meetings with senior…

India’s pharmaceutical sector has continued to attract sustained investor interest, even amid periods of broader market…